Indio (111in) Dtpa Curium Pharma Spain (Indium (111in) Pentetate)

Indium-111 is chelated to pentetate, creating a complex that stays within the extracellular and cerebrospinal fluid spaces after intrathecal injection. The isotope emits gamma photons that are captured by a gamma camera, producing detailed images of CSF circulation, leak sites, and shunt function.

The dose of Indio is determined by the prescribing physician based on the specific diagnostic indication, patient characteristics, and institutional protocols. The kit is supplied for radiolabeling, and the final administered activity is calculated by the nuclear medicine team.

The safety of Indio in pregnancy or lactation has not been established. Because it involves a radioactive isotope, it should be used only if the potential diagnostic benefit outweighs any possible risk to the fetus or infant, and only under specialist guidance.

To order Indio, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Indio (Indium-111 pentetate) offers gamma‑emitting imaging suitable for planar and SPECT studies, providing high‑resolution localization of CSF leaks and shunt patency. Alternative agents, such as Technetium‑99m DTPA, have shorter half‑lives and may be preferred for rapid studies, while Indium‑111 allows longer imaging windows but involves higher radiation exposure.

Indio should be stored at ambient temperature, protected from light and moisture, and kept in its original sealed packaging until use. The kit must be handled in a controlled environment to avoid contamination and ensure the radiolabeling process remains sterile.

Indio is administered by a trained clinician via intrathecal injection, typically through a lumbar puncture. The radiolabeled solution is injected into the cerebrospinal fluid, after which imaging is performed using a gamma camera at predefined time points.

Serious risks include allergic reactions ranging from rash to anaphylaxis, meningitis from procedural contamination, radiation‑induced myelopathy, severe hypotension, and rare neurologic events such as seizures. Prompt recognition and management of these events are essential.

Indio should not be used in patients with known hypersensitivity to indium‑111, pentetate, or any component of the kit, in those with active central nervous system infections, or in individuals where intrathecal injection is contraindicated (e.g., coagulopathy, severe spinal deformities).